[Heparin; mechanism of action and clinical indications]. 1955

C G DIMITRIU, and S RUSETEANU

UI MeSH Term Description Entries
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C G DIMITRIU, and S RUSETEANU
June 1991, Current opinion in rheumatology,
C G DIMITRIU, and S RUSETEANU
July 1990, Bailliere's clinical haematology,
C G DIMITRIU, and S RUSETEANU
October 1971, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C G DIMITRIU, and S RUSETEANU
March 1979, Schweizerische medizinische Wochenschrift,
C G DIMITRIU, and S RUSETEANU
January 1978, Fortschritte der Medizin,
C G DIMITRIU, and S RUSETEANU
January 1986, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie,
C G DIMITRIU, and S RUSETEANU
January 1968, Il Friuli medico,
C G DIMITRIU, and S RUSETEANU
February 1957, Schweizerische medizinische Wochenschrift,
C G DIMITRIU, and S RUSETEANU
January 1957, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
C G DIMITRIU, and S RUSETEANU
August 1990, Revue medicale de Liege,
Copied contents to your clipboard!